Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in Metastatic and Locally Advanced Pancreatic Cancer
NCT06539806Completed
- Sponsor
- Tanta University
- Start
- Jul 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of losartan in pancreatic cancer (PC) (6 arms), sponsored by Tanta University. Primary endpoint: Patient Response Rate at 1 year. Started Jul 2024; status: completed.
02
Drugs
losartan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06539806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06539806.